Merrill scores twice as Reckitt lands Boots Healthcare

Merrill Lynch has worked on its second deal in a week with Boots, the UK retailer, after advising Reckitt Benckiser on its £1.9bn (€2.8bn) purchase of Boots' over-the-counter medicines business.

On Monday, the bank advised Alliance Unichem, the pharmacy chain, on its £7bn (€5.8bn) nil-premium merger with Boots.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump